Prognostic impact of peripheral blood WT1 mRNA dynamics in patients with acute myeloid leukemia treated with venetoclax combination therapy

ConclusionThis study demonstrates thatWT1 mRNA dynamics can be a useful marker for assessing long-term prognosis of VEN combination therapy for AML.
Source: International Journal of Clinical Oncology - Category: Cancer & Oncology Source Type: research